Living with Cancer - The number of cells containing the genetic defect in some leukemias can be reduced

Post An Ad Marketplace Cars Dating Jobs Real Estate

Sports Blogs Fashion Harry Potter Make Us Rich Movies Travel NYP Home Page Tempo TV Video Games Health: IVF Weight Loss

Past Editions Archives AvantGo Classroom Extra Coupons E-Edition Past Editions Liberty Medals Parade Magazine Site Map Special Sections Story Index Tempo Weekend Guide

Pulse Home Movies Music Food Fashion Theater Health Travel Comics & Games Horoscope Dating Weddings

Cancer Living with Cancer

The number of cells containing the genetic defect in some leukemias can be reduced

Today, highly sensitive tests can identify the presence of the gene responsible for chronic myeloid leukemia (CML). Just one cancerous cell can be detected among hundreds of thousands of cells. The faulty gene, found on the Philadelphia chromosome, creates an enzyme that interferes with the regulation of white blood cell production. The result is an explosion in the growth of white blood cells, the hallmark of CML. A novel medication tackles the disease by reducing the number of white blood cells and the number of cells containing the faulty gene.

RELATED PROGRAMS
Video	-	The Faulty Gene Behind Chronic Myeloid Leukemia Transcript
Video	-	Monitoring Therapy in Chronic Myeloid Leukemia Transcript
Article	-	Making Tough Treatment Decisions About Leukemia

HealthVideo.com © 2008 NBC Digital Health Network, Inc. All Rights Reserved
Privacy Policy - Disclaimer - Editorial Policy
We subscribe to the HONcode principles. Verify here

News

Sports

Gossip

Business

Entertainment

Post Opinion

Classifieds

Miscellaneous

User Services

NEW YORK POST is a registered trademark of NYP Holdings, Inc. NYPOST.COM, NYPOSTONLINE.COM, and NEWYORKPOST.COM are trademarks of NYP Holdings, Inc.